Autoimmunity in coxsackievirus B3 induced myocarditis

References

• Feldman AM, McNamara D. Myocarditis. N Engl J Med 2000; 343: 1388–1398
   PubMed Web of Science ®Google Scholar
• Bowles NE, Ni J, Kearney DL, Pauschinger M, Schultheiss HP, McCarthy R, Hare J, Bricker JT, Bowles KR, Towbin JA. Detection of viruses in myocardial tissues by polymerase chain reaction. Evidence of adenovirus as a common cause of myocarditis in children and adults. J Am Coll Cardiol 2003; 42: 466–472
   PubMed Web of Science ®Google Scholar
• Rueckert RR. Picornaviridae: The viruses and their replication. Fundamental virology3rd, BN Fields, DM Knipe, PM Howley. Lippincott-Roven, Philadelphia 1996; 477–522
   Google Scholar
• Kerekatte V, Keiper BD, Badorff C, Cai A, Knowlton KU, Rhoads RE. Cleavage of poly(A)-binding protein by coxsackievirus 2A protease in vitro and in vivo: Another mechanism for host protein synthesis shutoff?. J Virol 1999; 73: 709–717
   PubMedGoogle Scholar
• Feuer R, Mena I, Pagarigan R, Slifka MK, Whitton JL. Cell cycle status affects coxsackievirus replication, persistence, and reactivation in vitro. J Virol 2002; 76: 4430–4440
   PubMed Web of Science ®Google Scholar
• Feuer R, Mena I, Pagarigan RR, Hassett DE, Whitton JL. Coxsackievirus replication and the cell cycle: A potential regulatory mechanism for viral persistence/latency. Med Microbiol Immunol (Berl) 2004; 193: 83–90
   PubMed Web of Science ®Google Scholar
• Kandolf R, Sauter M, Aepinus C, Schnorr JJ, Selinka HC, Klingel K. Mechanisms and consequences of enterovirus persistence in cardiac myocytes and cells of the immune system. Virus Res 1999; 62: 149–158
   Google Scholar
• Horwitz M, Sarvetnick N. Viruses, host responses, and autoimmunity. Immunol Rev 1999; 169: 241–253
   PubMed Web of Science ®Google Scholar
• Fujinami RS, Oldstone MBA. Amino acid homology between the encephalitogenic site of myelin basic protein and virus: Mechanism for autoimmunity. Science 1985; 230: 1043–1045
   PubMed Web of Science ®Google Scholar
• Fujinami RS, Oldstone MBA. Molecular mimicry as a mechanism for virus-induced autoimmunity. Immunol Res 1989; 8: 3–15
   PubMed Web of Science ®Google Scholar
• Rose NR, Mackay IR. Molecular mimicry: A critical look at exemplary instances in human diseases. Cell Mol Life Sci 2000; 57: 542–551
   PubMed Web of Science ®Google Scholar
• Schwimmbeck PL, Oldstone MBA. Molecular mimicry between human leukocyte antigen B27 and Klebsiella. Consequences for spondyloarthropathies. Am J Med 1988; 85: 51–53
   PubMed Web of Science ®Google Scholar
• Schwimmbeck PL, Oldstone MBA. Klebsiella pneumoniae and HLA B27-associated diseases of Reiter's syndrome and ankylosing spondylitis. Curr Top Microbiol Immunol 1989; 145: 45–56
   PubMed Web of Science ®Google Scholar
• Schwimmbeck PL, Dyrberg T, Drachman DB, Oldstone MBA. Molecular mimicry and myasthenia gravis. An autoantigenic site of the acetylcholine receptor alpha-subunit that has biologic activity and reacts immunochemically with herpes simplex virus. J Clin Investig 1989; 84: 1174–1180
   PubMed Web of Science ®Google Scholar
• Vreugdenhil GR, Batstra MR, Aanstoot HJ, Melchers WJ, Galama JM. Analysis of antibody responses against coxsackie virus B4 protein 2C and the diabetes autoantigen GAD(65). J Med Virol 1999; 59: 256–261
   Google Scholar
• Hiemstra HS, Schloot NC, van Veelen PA, Willemen SJ, Franken KL, van Rood JJ, de Vries RR, Chaudhuri A, Behan PO, Drijfhout JW, Roep BO. Cytomegalovirus in autoimmunity: T cell crossreactivity to viral antigen and autoantigen glutamic acid decarboxylase. Proc Natl Acad Sci USA 2001; 98: 3988–3991
   PubMed Web of Science ®Google Scholar
• Cunningham MW, Hall NK, Krisher KK, Spanier AM. A study of anti-group A streptococcal monoclonal antibodies crossreactive with myosin. J Immunol 1986; 136: 293–298
   PubMed Web of Science ®Google Scholar
• Wucherpfennig KW, Strominger JL. Molecular mimicry in T cell-mediated autoimmunity: Viral peptides activate human T cell clones specific for myelin basic protein. Cell 1995; 80: 695–705
   PubMed Web of Science ®Google Scholar
• Stathopoulou EA, Routsias JG, Stea EA, Moutsopoulos HM, Tzioufas AG. Cross-reaction between antibodies to the major epitope of Ro60 kDa autoantigen and a homologous peptide of Coxsackie virus 2B protein. Clin Exp Immunol 2005; 141: 148–154
   PubMed Web of Science ®Google Scholar
• Ramos-Casals M, De Vita S, Tzioufas AG. Hepatitis C, Sjogren's syndrome and B-cell lymphoma: Linking infection, autoimmunity and cancer. Autoimmun Rev 2005; 4: 8–15
   PubMed Web of Science ®Google Scholar
• Evavold BD, Sloan-Lancaster J, Wilson KJ, Rothbard JB, Allen PM. Specific T cell recognition of minimally homologous peptides: Evidence for multiple endogenous ligands. Immunity 1995; 2: 655–663
   PubMed Web of Science ®Google Scholar
• Gauntt CJ, Arizpe HM, Higdon AL, Wood HJ, Bowers DF, Rozek MM, Crawley R. Molecular mimicry: Anti-coxsackievirus B3 neutralizing monoclonal antibodies and myocarditis. J Immunol 1995; 154: 2983–2995
   Google Scholar
• Gauntt CJ, Higdon AL, Arizpe HM, Tamayo MR, Crawley R, Henkel RD, Pereira ME, Tracy SM, Cunningham MW. Epitopes shared between coxsackievirus B3 (CVB3) and normal heart tissue contribute to CVB3-induced murine myocarditis. Clin Immunol Immunopathol 1993; 68: 129–134
   PubMedGoogle Scholar
• Gauntt C, Higdon A, Bowers D, Maull E, Wood J, Crawley R. What lessons can be learned from animal model studies in viral heart disease?. Scand J Infect Dis Suppl 1993; 88: 49–65
   PubMedGoogle Scholar
• Gauntt C. Roles of the humoral response in Coxsackievirus B-induced disease. Curr Top Microbiol Immunol 1997; 223: 259–282
   PubMed Web of Science ®Google Scholar
• Huber S, Simpson K, Weller A, Herzum M. Immunopathogenic mechanisms in experimental myocarditis: Evidence for autoimmunity to the virus receptor and antigenic mimicry between the virus and cardiocyte. New concepts in viral heart disease: Virology, immunology and clinical management, H-P Schulthess. Springer-Verlag, Berlin 1988; 179–187
   Google Scholar
• Cunningham MW, Antone SM, Gulizia JM, McManus BM, Fischetti VA, Gauntt CJ. Cytotoxic and viral neutralizing antibodies crossreact with streptococcal M protein, enteroviruses, and human cardiac myosin. Proc Natl Acad Sci USA 1992; 89: 1320–1324
   PubMed Web of Science ®Google Scholar
• Huber SA, Moraska A, Cunningham M. Alterations in major histocompatibility complex association of myocarditis induced by coxsackievirus B3 mutants selected with monoclonal antibodies to group A streptococci. Proc Natl Acad Sci USA 1994; 91: 5543–5547
   PubMed Web of Science ®Google Scholar
• Huber SA, Cunningham MW. Streptococcal M protein peptide with similarity to myosin induces CD4+T cell-dependent myocarditis in MRL/++ mice and induces partial tolerance against coxsakieviral myocarditis. J Immunol 1996; 156: 3528–3534
   PubMedGoogle Scholar
• Huber SA. Autoimmunity in myocarditis: Relevance of animal models. Clin Immunol Immunopathol 1997; 83: 93–102
   PubMedGoogle Scholar
• Cheynier R, Henrichwark S, Wain-Hobson S. Somatic hypermutation of the T cell receptor V beta gene in microdissected splenic white pulps from HIV-1-positive patients. Eur J Immunol 1998; 28: 1604–1610
   Google Scholar
• Zheng B, Xue W, Kelsoe G. Locus-specific somatic hypermutation in germinal centre T cells. Nature 1994; 372: 556–559
   Google Scholar
• Weiss U, Rajewsky K. The repertoire of somatic antibody mutants accumulating in the memory compartment after primary immunization is restricted through affinity maturation and mirrors that expressed in the secondary response. J Exp Med 1990; 172: 1681–1689
   PubMedGoogle Scholar
• Sercarz EE, Lehmann PV, Ametani A, Benichou G, Miller A, Moudgil K. Dominance and crypticity of T cell antigenic determinants. Annu Rev Immunol 1993; 11: 729–766
   PubMed Web of Science ®Google Scholar
• Lanzavecchia A. How can cryptic epitopes trigger autoimmunity?. J Exp Med 1995; 181: 1945–1948
   PubMed Web of Science ®Google Scholar
• Iezzi G, Karjalainen K, Lanzavecchia A. The duration of antigenic stimulation determines the fate of naïve and effector T cells. Immunity 1998; 8: 89–95
   PubMed Web of Science ®Google Scholar
• Steinman RM. The dendritic cell system and its role in immunogenicity. Annu Rev Immunol 1991; 9: 271–296
   PubMed Web of Science ®Google Scholar
• Flynn K, Mullbacher A. The generation of memory antigen-specific cytotoxic T cell responses by CD28/CD80 interactions in the absence of antigen. Eur J Immunol 1997; 27: 456–462
   Google Scholar
• Vidard L, Rock KL, Benacerraf B. Heterogeneity in antigen processing by different types of antigen-presenting cells. Effect of cell culture on antigen processing ability. J Immunol 1992; 149: 1905–1911
   PubMed Web of Science ®Google Scholar
• Gresser O, Weber E, Hellwig A, Riese S, Regnier-Vigouroux A. Immunocompetent astrocytes and microglia display major differences in the processing of the invariant chain and in the expression of active cathepsin L and cathepsin S. Eur J Immunol 2001; 31: 1813–1824
   PubMed Web of Science ®Google Scholar
• Caporossi AP, Bruno G, Salemi S, Mastroianni C, Falciano M, Salotti A, Bergami N, Santilio I, Nisini R, Barnaba V. Autoimmune T-cell response to the CD4 molecule in HIV-infected patients. Viral Immunol 1998; 11: 9–17
   Google Scholar
• Simitsek PD, Campbell DG, Lanzavecchia A, Fairweather N, Watts C. Modulation of antigen processing by bound antibodies can boost or suppress class II major histocompatibility complex presentation of different T cell determinants. J Exp Med 1995; 181: 1957–1963
   PubMedGoogle Scholar
• Driessen C, Lennon-Dumenil AM, Ploegh HL. Individual cathepsins degrade immune complexes internalized by antigen-presenting cells via Fcgamma receptors. Eur J Immunol 2001; 31: 1592–1601
   Google Scholar
• Li Y, Heuser JS, Kosanke SD, Hemric M, Cunningham MW. Cryptic epitope identified in rat and human cardiac myosin S2 region induces myocarditis in the Lewis rat. J Immunol 2004; 172: 3225–3234
   PubMed Web of Science ®Google Scholar
• Han YS, Chang GG, Juo CG, Lee HJ, Yeh SH, Hsu JT, Chen X. Papain-like protease 2 (PLP2) from severe acute respiratory syndrome coronavirus (SARS-CoV): Expression, purification, characterization, and inhibition. Biochemistry 2005; 44: 10349–10359
   PubMed Web of Science ®Google Scholar
• Lehmann-Che J, Giron ML, Delelis O, Lochelt M, Bittoun P, Tobaly-Tapiero J, de The H, Saib A. Protease-dependent uncoating of a complex retrovirus. J Virol 2005; 79: 9244–9253
   PubMed Web of Science ®Google Scholar
• Semler BL. Resistance is futile. Nat Genet 2005; 37: 665–666
   Google Scholar
• Badorff C, Lee GH, Lamphear BJ, Martone ME, Campbell KP, Rhoads RE, Knowlton KU. Enteroviral protease 2A cleaves dystrophin: Evidence of cytoskeletal disruption in an acquired cardiomyopathy. Nat Med 1999; 5: 320–326
   PubMedGoogle Scholar
• Badorff C, Lee GH, Knowlton KU. Enteroviral cardiomyopathy: Bad news for the dystrophin-glycoprotein complex. Herz 2000; 25: 227–232
   PubMed Web of Science ®Google Scholar
• Monaco JJ. Pathways for the processing and presentation of antigens to T cells. J Leukoc Biol 1995; 57: 543–547
   PubMed Web of Science ®Google Scholar
• Cadwell K, Coscoy L. Ubiquitination on nonlysine residues by a viral E3 ubiquitin ligase. Science 2005; 309: 127–130
   PubMed Web of Science ®Google Scholar
• Si X, McManus BM, Zhang J, Yuan J, Cheung C, Esfandiarei M, Suarez A, Morgan A, Luo H. Pyrrolidine dithiocarbamate reduces coxsackievirus B3 replication through inhibition of the ubiquitin-proteasome pathway. J Virol 2005; 79: 8014–8023
   PubMed Web of Science ®Google Scholar
• Luo H, Zhang J, Cheung C, Suarez A, McManus BM, Yang D. Proteasome inhibition reduces coxsackievirus B3 replication in murine cardiomyocytes. Am J Pathol 2003; 163: 381–385
   PubMed Web of Science ®Google Scholar
• Luo H, Zhang J, Dastvan F, Yanagawa B, Reidy MA, Zhang HM, Yang D, Wilson JE, McManus BM. Ubiquitin-dependent proteolysis of cyclin D1 is associated with coxsackievirus-induced cell growth arrest. J Virol 2003; 77: 1–9
   Google Scholar
• Kaya Z, Dohmen KM, Wang Y, Schlichting J, Afanasyeva M, Leuschner F, Rose NR. Cutting edge: A critical role for IL-10 in induction of nasal tolerance in experimental autoimmune myocarditis. J Immunol 2002; 168: 1552–1556
   PubMed Web of Science ®Google Scholar
• Bebo BF, Jr, Fyfe-Johnson A, Adlard K, Beam AG, Vandenbark AA, Offner H. Low-dose estrogen therapy ameliorates experimental autoimmune encephalomyelitis in two different inbred mouse strains. J Immunol 2001; 166: 2080–2089
   PubMed Web of Science ®Google Scholar
• Pelegri C, Kuhnlein P, Buchner E, Schmidt CB, Franch A, Castell M, Hunig T, Emmrich F, Kinne RW. Depletion of gamma delta T cells does not prevent or ameliorate, but rather aggravates rat adjuvant arthritis. Arthritis Rheum 1996; 39: 204–215
   Google Scholar
• Netea MG, Van der Meer JW, Kullberg BJ. Toll-like receptors as an escape mechanism from the host defense. Trends Microbiol 2004; 12: 484–488
   PubMed Web of Science ®Google Scholar
• O'Neill LA. TLRs: Professor Mechnikov, sit on your hat. Trends Immunol 2004; 25: 687–693
   Google Scholar
• Lauw FN, Caffrey DR, Golenbock DT. Of mice and man: TLR11 (finally) finds profilin. Trends Immunol 2005; 26: 509–511
   PubMed Web of Science ®Google Scholar
• Hasan U, Chaffois C, Gaillard C, Saulnier V, Merck E, Tancredi S, Guiet C, Briere F, Vlach J, Lebecque S, Trinchieri G, Bates EE. Human TLR10 is a functional receptor, expressed by B cells and plasmacytoid dendritic cells, which activates gene transcription through MyD88. J Immunol 2005; 174: 2942–2950
   PubMed Web of Science ®Google Scholar
• Vogel SN, Fitzgerald KA, Fenton MJ. TLRs: Differential adapter utilization by toll-like receptors mediates TLR-specific patterns of gene expression. Mol Interv 2003; 3: 466–477
   PubMedGoogle Scholar
• Peng G, Guo Z, Kiniwa Y, Voo KS, Peng W, Fu T, Wang DY, Li Y, Wang HY, Wang RF. Toll-like receptor 8-mediated reversal of CD4+ regulatory T cell function. Science 2005; 309: 1380–1384
   PubMed Web of Science ®Google Scholar
• Youn HS, Lee JY, Fitzgerald KA, Young HA, Akira S, Hwang DH. Specific inhibition of MyD88-independent signaling pathways of TLR3 and TLR4 by resveratrol: Molecular targets are TBK1 and RIP1 in TRIF complex. J Immunol 2005; 175: 3339–3346
   PubMed Web of Science ®Google Scholar
• Hosoi T, Suzuki S, Nomura J, Ono A, Okuma Y, Akira S, Nomura Y. Bacterial DNA induced iNOS expression through MyD88-p38 MAP kinase in mouse primary cultured glial cells. Brain Res Mol Brain Res 2004; 124: 159–164
   Google Scholar
• Lowenstein CJ, Hill SL, Lafond-Walker A, Wu J, Allen G, Landavere M, Rose NR, Herskowitz A. Nitric oxide inhibits viral replication in murine myocarditis. J Clin Investig 1996; 97: 1837–1843
   PubMed Web of Science ®Google Scholar
• Horng T, Barton GM, Flavell RA, Medzhitov R. The adaptor molecule TIRAP provides signalling specificity for Toll-like receptors. Nature 2002; 420: 329–333
   PubMed Web of Science ®Google Scholar
• Eriksson U, Kurrer MO, Sonderegger I, Iezzi G, Tafuri A, Hunziker L, Suzuki S, Bachmaier K, Bingisser RM, Penninger JM, Kopf M. Activation of dendritic cells through the interleukin 1 receptor 1 is critical for the induction of autoimmune myocarditis. J Exp Med 2003; 197: 323–331
   PubMedGoogle Scholar
• Eriksson U, Ricci R, Hunziker L, Kurrer MO, Oudit GY, Watts TH, Sonderegger I, Bachmaier K, Kopf M, Penninger JM. Dendritic cell-induced autoimmune heart failure requires cooperation between adaptive and innate immunity. Nat Med 2003; 9: 1484–1490, Published erratum in: Nat Med 2004;10:105
   PubMed Web of Science ®Google Scholar
• Fairweather D, Frisancho-Kiss S, Rose NR. Viruses as adjuvants for autoimmunity: Evidence from Coxsackievirus-induced myocarditis. Rev Med Virol 2005; 15: 17–27
   PubMed Web of Science ®Google Scholar
• Vanderlugt CL, Miller SD. Epitope spreading in immune-mediated diseases: Implications for immunotherapy. Nat Rev Immunol 2002; 2: 85–95
   PubMed Web of Science ®Google Scholar
• Miller SD, Katz-Levy Y, Neville KL, Vanderlugt CL. Virus-induced autoimmunity: Epitope spreading to myelin autoepitopes in Theiler's virus infection of the central nervous system. Adv Virus Res 2001; 56: 199–217
   Google Scholar
• Latif N, Zhang H, Archard LC, Yacoub MH, Dunn MJ. Characterization of anti-heart antibodies in mice after infection with coxsackie B3 virus. Clin Immunol 1999; 91: 90–98
   PubMedGoogle Scholar
• Schwimmbeck PL, Bigalke B, Schulze K, Pauschinger M, Kuhl U, Schultheiss HP. The humoral immune response in viral heart disease: Characterization and pathophysiological significance of antibodies. Med Microbiol Immunol (Berl) 2004; 193: 115–119
   Google Scholar
• Pankuweit S, Portig I, Lottspeich F, Maisch B. Autoantibodies in sera of patients with myocarditis: Characterization of the corresponding proteins by isoelectric focusing and N-terminal sequence analysis. J Mol Cell Cardiol 1997; 29: 77–84
   PubMedGoogle Scholar
• Caforio AL, Mahon NJ, Mckenna WJ. Cardiac autoantibodies to myosin and other heart-specific autoantigens in myocarditis and dilated cardiomyopathy. Autoimmunity 2001; 34: 199–204
   PubMed Web of Science ®Google Scholar
• Caforio AL, Mahon NJ, Tona F, McKenna WJ. Circulating cardiac autoantibodies in dilated cardiomyopathy and myocarditis: Pathogenetic and clinical significance. Eur J Heart Fail 2002; 4: 411–417
   PubMed Web of Science ®Google Scholar
• Cunningham MW, Antone SM, Smart M, Liu R, Kosanke S. Molecular analysis of human cardiac myosin-cross-reactive B- and T-cell epitopes of the group A streptococcal M5 protein. Infect Immun 1997; 65: 3913–3923
   PubMed Web of Science ®Google Scholar